Medication info

Altimo Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletSucralfate Hydrate›300mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tablet
Manufacturer / importer
Hawon Pharmaceutical Co., Ltd.
Appearance
Green round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 201904774 · Approved 2019.07.16

This product's status changed to Expired on 2024.07.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, etc.) and prevention of Mendelson syndrome before anesthesia
Who takes it
Adults
Adult dose
○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant treatment to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, while ulcers generally heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Ingredients

Manufacturer
Hawon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, etc.) and prevention of Mendelson syndrome before anesthesia

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs
View approved original text

This medication is used to treat various diseases of the digestive system, such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson's syndrome before anesthesia and is effective for treating ulcers that may occur post-surgery, as well as for gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It helps protect the mucosa of the stomach and duodenum and regulates acid secretion, alleviating symptoms. This medication assists in improving gastrointestinal issues and reducing patient discomfort.

How to take

Adult dose

○ Adults Usually, take 2 tablets orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to the treatment of ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant treatment to prevent gastric or duodenal ulcers during long-term NSAID use. Conditions caused by NSAID use usually heal within 4 weeks, while ulcers generally heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Take 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 4 tablets four times daily. 3) Zollinger-Ellison syndrome Initiate treatment with 2 tablets three times daily and increase the dose as needed. For severe disease, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and take 2 tablets twice daily. 5) Pre-anesthetic medication (prevention of Mendelson syndrome) Take 2 tablets 2 hours before induction of anesthesia. It is also preferable to take 2 tablets on the night before surgery.

Precautions

This medication should not be administered to patients undergoing dialysis treatment or those with kidney function issues. Patients who have experienced allergic reactions to this medication or its ingredients should also avoid its use. This medication should not be administered to patients who have a history of the rare disease acute porphyria as it may exacerbate symptoms. It is also safer not to administer this drug to patients who have undergone upper gastrointestinal surgery or to pregnant women, women with a possibility of pregnancy, premature infants, and newborns. Patients who are on a potassium-restricted diet should exercise caution. Caution should also be exercised when prescribing this medication to patients with liver dysfunction, a history of drug allergies, the elderly, and those who have previously had kidney issues. If taken with NSAIDs, especially in the elderly or those with a history of peptic ulcers, regular check-ups are necessary. This medication may mask symptoms of gastric cancer, so if new or changed indigestion symptoms occur in patients with gastric ulcers or those over middle age, it must be confirmed whether they are malignant before administration. Patients with Helicobacter pylori-induced gastric and duodenal ulcers must undergo eradication therapy concurrently. Critically ill patients in intensive care units are at risk of gastric stone formation and should be approached with caution. The aluminum component of this medication may interfere with phosphate absorption, thus caution is needed for patients with hypophosphatemia. Those who have difficulty swallowing are at risk of respiratory complications and should be approached carefully. While taking this medication, rare severe allergic reactions or shock may occur, so if symptoms arise, administration should be stopped immediately and medical personnel informed. If skin rashes, urticaria, dyspnea, or hypotension due to hypersensitivity occur, medication should be stopped and treated. Decreased blood cell counts or liver function abnormalities may appear; if symptoms arise, testing is required. Cardiac rhythm disturbances or vasculitis have been reported rarely, and caution is advised if related symptoms occur. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and stool color may change, which typically does not require special treatment. Severe dizziness, drowsiness, confusion, or seizures may occur, so if abnormalities are present, consultation with medical personnel is essential. Gynecomastia or changes in sexual function have been reported rarely, but a clear causal relationship has not been established. Muscle pain or joint pain may occur, and in severe cases, there is a possibility of serious muscle damage, such as rhabdomyolysis, so caution is advised. Skin rashes or hair loss may occur rarely. If not used in the long term, and if there is no therapeutic effect, it's better to switch to another medication. The elderly, patients with chronic lung disease, diabetes, and those with weak immunity may have an increased risk of pneumonia, so caution is needed. If dizziness or drowsiness occurs during use, avoid driving or operating dangerous machinery. This medication may interact with other drugs, so particularly inform medical personnel if taking anticoagulants, some antibiotics, or anticonvulsants. It is safest not to use this medication during pregnancy or breastfeeding. Safety in children has not been established, so it's better not to use it. In cases of overdose, emergency measures such as vomiting or gastric lavage may be necessary. This medication reduces gastric acid secretion and can promote bacterial growth in the stomach, so long-term use may require ophthalmological examinations.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 57 more
  • thrombocytopenia
  • elevated serum enzyme levels
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contraction
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heavy head
  • disease sensation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorder
  • consciousness disorder
  • hepatic myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress, and it is best to keep it at room temperature between 1°C and 30°C. Proper storage will maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Green round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.